Literature DB >> 25989947

Healthcare-associated outbreaks due to Mucorales and other uncommon fungi.

Setareh Davoudi1, Linda S Graviss2, Dimitrios P Kontoyiannis2.   

Abstract

BACKGROUND: Healthcare-associated outbreaks of fungal infections, especially with uncommon and emerging fungi, have become more frequent in the past decade. MATERIALS AND
METHOD: Here, we reviewed the history and definition of healthcare-associated outbreaks of uncommon fungal infections and discussed the principles of investigating, containing and treatment of these outbreaks.
RESULTS: In case of these uncommon diseases, occurrence of two or more cases in a short period is considered as an outbreak. Contaminated medical devices and hospital environment are the major sources of these outbreaks. Care must be taken to differentiate a real infection from colonization or contamination. Defining and identifying cases, describing epidemiologic feature of cases, finding and controlling the source of the outbreak, treating patients, and managing asymptomatic exposed patients are main steps for outbreak elimination. These fungal outbreaks are not only difficult to detect but also hard to treat. Early initiation of appropriate antifungal therapy is strongly associated with improved outcomes in infected patients. Choice of antifungal drugs should be made based on spectrum, pharmacodynamic and pharmacokinetic characteristics and adverse effects of available drugs. Combination antifungal therapy and surgical intervention may be also helpful in selected cases.
CONCLUSIONS: A multidisciplinary approach and close collaboration between all key partners are necessary for successful control of fungal outbreaks.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Healthcare-associated; Mucorales; outbreak; uncommon fungi

Mesh:

Substances:

Year:  2015        PMID: 25989947     DOI: 10.1111/eci.12467

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.

Authors:  Anuradha Chowdhary; Pradeep Kumar Singh; Shallu Kathuria; Ferry Hagen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

2.  Rhizopus arrhizus Invasive Infection due to Self-Inflicted Scratch Injuries in a Diabetic Patient with Non-ketotic Acidosis.

Authors:  Luis Buzón Martín; Miguel Ángel Morán Rodríguez; Nicole Mercier; Maria Ortega Lafont; Eva Ojeda Fernández; Ana Ruiz de la Parte; Miguel Estefanía
Journal:  Mycopathologia       Date:  2017-06-23       Impact factor: 2.574

3.  How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers.

Authors:  Alexander J Sundermann; Cornelius J Clancy; A William Pasculle; Guojun Liu; Richard B Cumbie; Eileen Driscoll; Ashley Ayres; Lisa Donahue; Steven A Pergam; Lilian Abbo; David R Andes; Pranatharthi Chandrasekar; Alison L Galdys; Kimberly E Hanson; Kieren A Marr; Jeanmarie Mayer; Seema Mehta; Michele I Morris; John Perfect; Sanjay G Revankar; Becky Smith; Sankar Swaminathan; George R Thompson; Merin Varghese; Jose Vazquez; Estella Whimbey; John R Wingard; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079

Review 4.  Potential Use of Alginate-Based Carriers As Antifungal Delivery System.

Authors:  Cristina de Castro Spadari; Luciana B Lopes; Kelly Ishida
Journal:  Front Microbiol       Date:  2017-01-30       Impact factor: 5.640

Review 5.  Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention.

Authors:  Marie-Elisabeth Bougnoux; Sophie Brun; Jean-Ralph Zahar
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-27       Impact factor: 4.887

Review 6.  Therapy of Mucormycosis.

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Amalia Anastasopoulou; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2018-07-31

7.  Mucormycosis in pediatric oncology patients: a hospital outbreak investigation report.

Authors:  Ahmed I H Saleem; Asim Alsaedi; Maher Alharbi; Shaker Abdullah; Ali Al Rabou; Mona AlDabbagh
Journal:  Infect Prev Pract       Date:  2021-11-20

Review 8.  Biotic Environments Supporting the Persistence of Clinically Relevant Mucormycetes.

Authors:  Malcolm D Richardson; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2019-12-20

9.  Necrotizing fasciitis caused by Apophysomyces variabilis in a burn patient.

Authors:  Arghadip Samaddar; Anuradha Sharma; Vinod Kumar Maurya; Vibhor Tak
Journal:  IDCases       Date:  2019-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.